Trade Summary

1 week ago, AH Bio Fund IV, L.P., serving as 10% owner Owner at Braveheart Bio, Inc. (BRVE), purchased 1,100,000 shares at $18.00 per share, for a total transaction value of $19,800,000.00. Following this transaction, AH Bio Fund IV, L.P. now holds 10,232,420 shares of BRVE.

This purchase represents a 12.05% increase in AH Bio Fund IV, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 7, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 11, 2026 at 5:53 PM ET, 4 days after the trade was made.

Braveheart Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.